Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: A pilot study

Retina

Volumn 26, Issue 7, 2006, Pages 780-785

  Eandi, Chiara M ^a   Ober, Michael D ^a   Freund, K Bailey ^a   Klais, Christina M ^a   Slakter, Jason S ^a   Sorenson, John A ^a   Yannuzzi, Lawrence A ^a  

^a EAR AND THROAT HOSPITAL   (United States)

Author keywords

Anecortave acetate; Idiopathic perifoveal telangiectasia; Macula; Retinal telangiectasia; Subretinal neovascularization

Indexed keywords

ANECORTAVE;

ADULT; AGED; ARTICLE; CANNULA; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; CLINICAL EXAMINATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC PERIFOVEAL TELANGIECTASIA; MALE; PILOT STUDY; PROSPECTIVE STUDY; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA LUTEA; RETINA NEOVASCULARIZATION; TELANGIECTASIA; VISION; VISUAL ACUITY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; CAPILLARY PERMEABILITY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PREGNADIENEDIOLS; PROSPECTIVE STUDIES; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; TELANGIECTASIS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33748653399     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iae.0000244262.91018.4d     Document Type: Article

References (17)

1. Gass DM, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993;100:1536-1546.
2. Engelbrecht NE, Aaberg TM, Sung J, Lewis ML. Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol 2002;120:320-324.
3. Maberley DA, Yannuzzi LA, Gitter K, et al. Radiation exposure: a new risk factor for idiopathic perifoveal telangiectasis. Ophthalmology 1999;106:2248-2252.
4. Park DW, Schatz H, McDonald HR, Johnson RN. Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis. Ophthalmology 1997;104:1838-1846.
5. Potter JP, Szabo SM, Chan EY, Morris AHC. Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 2002;133:149-151.
6. Berger AS, McCuen BW II, Brown GC, Brownlow RL. Surgical removal of subfoveal neovascularization in idiopathic juxtafoveolar retinal telangiectasis. Retina 1997;17:94-98.
7. Clark AF. AL-3789: a novel ophthalmic angiostatic steroid. Exp Opin Invest Drug 1997;6:1867-1877.
8. DeFaller JM, Clark AF. A new pharmacological treatment for angiogenesis. In: Taylor HR, ed. Pterygium. The Hague: Kugler Publications, 2000;159-181.
9. Penn JS, Rajaratnam VS, Collier RJ, Clark AF. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001;42:283-290.
10. The Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology 2003;110:2372-2383.
11. Yannuzzi LA, Bardal AM, Freund KB, et al. Idiopathic macular telangiectasia. Arch Ophthalmol 2006 (in press).
12. Chew EY. Parafoveal telangiectasis. In: Ryan SJ, ed. Medical Retina. St. Louis: Mosby, 2001:1434-1440.
13. Park DW, Schatz H, McDonald HR, Johnson RN. Fibrovascular tissue in bilateral juxtafoveal telangiectasis. Arch Ophthalmol 1996;114:1092-1096.
14. McNatt LG, Weimer L, Yanni J, Clark AF. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization. J Ocul Pharm Ther 1999;15:413-423.
15. Friedman SM, Mames RN, Stewart MW. Subretinal hemorrhage after grid laser photocoagulation for idiopathic juxtafoveolar retinal telangiectasis. Ophthalmic Surg 1993;24:551-553.
16. Casey R, Li WW. Factors controlling ocular angiogenesis. Am J Ophthalmol 1997;124:521-529.
17. BenEzra D, Griffin BW, Naftzir G, Shariff NA, Clark AF. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci 1997;38:1954-1962.